Company: FVN
Filing Date: 2025-05-30
Form Type: S-4/A
Source: 0001829126-25-004067
Chunk: 294

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-05-30
Form: S-4/A
Chunk 294
---
 the purchases of property and equipment.

Net cash used in investing activities amounted to RMB 65,704 and RMB 3,294 for the years ended September 30, 2023 and 2024, respectively, mainly derived from cash received from acquisition subsidiaries and the purchases of property and equipment.

Financing Activities

Net cash provided by financing activities amounted to RMB 0.4 million for the three months ended December 31, 2023, which included mainly derived from contribution from members and proceeds from banking facility.

Net cash used in financing activities amounted to RMB 0.2 million for the three months ended December 31, 2024, which included mainly derived from loans repay to parent and repayment of banking facility.

Net cash provided by financing activities amounted to RMB 83.5 million for the year ended September 30, 2023, which included mainly derived from loans from parent and proceeds from banking facility.

Net cash used in financing activities amounted to RMB 23.5 million for the year ended September 30, 2024, which included mainly derived from loans repay to parent and proceeds from banking facility.

<div align='center'>182</div>

<div align='center'>IMPLICATIONS OF BEING AN EMERGING GROWTH COMPANY</div>

New VIWO will qualify as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other burdens that are otherwise applicable generally to public companies. These provisions include:

| ● | The ability to include only two years of audited financial statements and only two years of related management’s discussion and analysis of financial condition and results of operations disclosure; and |
| ● | An exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002.                                      |

We may take advantage of these provisions for up to five years from incorporation or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company if we have more than US$1.235 billion in annual revenue, have more than US$700 million in market value of our ordinary shares held by non-affiliates or issue more than US$1 billion of non-convertible debt over a three-year period.

<div align='center'>183</div>

<div align='center'>GOVERNMENT REG